Craig Winstanley
Craig Winstanley
Verified email at liv.ac.uk
Title
Cited by
Cited by
Year
Pseudomonas genomes: diverse and adaptable
MW Silby, C Winstanley, SAC Godfrey, SB Levy, RW Jackson
FEMS microbiology reviews 35 (4), 652-680, 2011
6362011
Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic
K Cheng, RL Smyth, JRW Govan, C Doherty, C Winstanley, N Denning, ...
The Lancet 348 (9028), 639-642, 1996
4451996
Pseudomonas aeruginosa evolutionary adaptation and diversification in cystic fibrosis chronic lung infections
C Winstanley, S O’Brien, MA Brockhurst
Trends in microbiology 24 (5), 327-337, 2016
3842016
Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa
C Winstanley, MGI Langille, JL Fothergill, I Kukavica-Ibrulj, ...
Genome research 19 (1), 12-23, 2009
3492009
Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections
E Mowat, S Paterson, JL Fothergill, EA Wright, MJ Ledson, MJ Walshaw, ...
American journal of respiratory and critical care medicine 183 (12), 1674-1679, 2011
2442011
A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance
P Salunkhe, CHM Smart, JAW Morgan, S Panagea, MJ Walshaw, CA Hart, ...
Journal of bacteriology 187 (14), 4908-4920, 2005
2292005
Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients
M Al-Aloul, J Crawley, C Winstanley, CA Hart, MJ Ledson, MJ Walshaw
Thorax 59 (4), 334-336, 2004
2032004
The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections
C Winstanley, JL Fothergill
FEMS microbiology letters 290 (1), 1-9, 2009
1922009
Distribution of type III secretion gene clusters in Burkholderia pseudomallei, B. thailandensis and B. mallei
L Rainbow, CA Hart, C Winstanley
Journal of medical microbiology 51 (5), 374-384, 2002
1722002
Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer
M Prorok-Hamon, MK Friswell, A Alswied, CL Roberts, F Song, ...
Gut 63 (5), 761-770, 2014
1672014
Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain
JL Fothergill, S Panagea, CA Hart, MJ Walshaw, TL Pitt, C Winstanley
BMC microbiology 7 (1), 1-10, 2007
1482007
Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces
S Panagea, C Winstanley, MJ Walshaw, MJ Ledson, CA Hart
Journal of Hospital Infection 59 (2), 102-107, 2005
1462005
Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections
JL Fothergill, MJ Walshaw, C Winstanley
European Respiratory Journal 40 (1), 227-238, 2012
1452012
Role of environmental survival in transmission of Campylobacter jejuni
C Bronowski, CE James, C Winstanley
FEMS microbiology letters 356 (1), 8-19, 2014
1372014
Identification of type II and type III pyoverdine receptors from Pseudomonas aeruginosa
M de Chial, B Ghysels, SA Beatson, V Geoffroy, JM Meyer, T Pattery, ...
Microbiology 149 (4), 821-831, 2003
1292003
The bacterial flagellin gene as a biomarker for detection, population genetics and epidemiological analysis
C Winstanley, JAW Morgan
Microbiology (Reading, England) 143, 3071-3084, 1997
1221997
In vivo growth of Pseudomonas aeruginosa strains PAO1 and PA14 and the hypervirulent strain LESB58 in a rat model of chronic lung infection
I Kukavica-Ibrulj, A Bragonzi, M Paroni, C Winstanley, F Sanschagrin, ...
Journal of bacteriology 190 (8), 2804-2813, 2008
1092008
Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations
JL Fothergill, E Mowat, MJ Ledson, MJ Walshaw, C Winstanley
Journal of medical microbiology 59 (4), 472-481, 2010
1082010
Type III secretion systems and pathogenicity islands
C Winstanley, CA Hart
Journal of medical microbiology 50 (2), 116-126, 2001
1062001
Use of artificial sputum medium to test antibiotic efficacy against Pseudomonas aeruginosa in conditions more relevant to the cystic fibrosis lung
S Kirchner, JL Fothergill, EA Wright, CE James, E Mowat, C Winstanley
JoVE (Journal of Visualized Experiments), e3857, 2012
1052012
The system can't perform the operation now. Try again later.
Articles 1–20